Effeza Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
- Revenue Growth %
- Profit Growth 74.59%
- Ebitda 75.94%
- Net Worth -26.09%
- Total Assets 883.31%
About Effeza Science
Effeza Science Private Limited (ESPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2021 (Three years and two months 9 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.50 Cr.
Cara Pereira, Pramodkumar Dubey, and Oscar Pereira serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24246MH2021PTC372268
-
Company No.
372268
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Effeza Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cara Pereira
|
Director | 26-Nov-2021 | Current |
|
Pramodkumar Dubey
|
Director | 29-May-2023 | Current |
|
Oscar Pereira
|
Director | 26-Nov-2021 | Current |
Financial Performance of Effeza Science.
Effeza Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 74.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Effeza Science?
Unlock access to Effeza Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pkd Advisors LlpPramodkumar Dubey is a mutual person
-
Fairmount Healthcare Llp
Oscar Pereira is a mutual person
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2023 | Others | ₹3.50 Cr | Open |
How Many Employees Work at Effeza Science?
Unlock and access historical data on people associated with Effeza Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Effeza Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Effeza Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.